Efinaconazole
Back to searchMolecule Structure
Scientific Name
Efinaconazole
Description of the Drug
Efinaconazole is an antifungal agent used to treat onychomycosis, a fungal infection of the nail.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB09040
http://www.drugbank.ca/drugs/DB09040
Brand Name(s)
Jublia
Company Owner(s)
Teva Pharmaceuticals Usa Inc, Padagis Us Llc, Nivagen Pharmaceuticals Inc, Aurobindo Pharma Ltd, Zydus Worldwide Dmcc, Lupin Ltd, Bausch Health Americas Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Lanosterol 14-alpha demethylase | SINGLE PROTEIN | INHIBITOR | CHEMBL3307221 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL300738 | |
| DrugBank | DB09040 | |
| PubChem: Thomson Pharma | 14754104 | |
| PubChem | 489181 | |
| Nikkaji | J1.186.659J | |
| EPA CompTox Dashboard | DTXSID40167787 | |
| DrugCentral | 4874 | |
| ChemicalBook | CB21313343 | |
| rxnorm | JUBLIA | EFINACONAZOLE |
| ChEBI | 82718 | |
| ZINC | ZINC000000006251 |
